Cambiar Pharma Private Limited

Cambiar Pharma Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24304TG2017PTC113978 Incorporated 10 January 2017 ROC Hyderabad HQ Secunderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹9.2 Lakh
▲ 20% YoY
Net loss · FY 2023
₹7,270
Net margin -0.8%
EBITDA · FY 2023
-₹4,095
EBITDA margin -0.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Cambiar Pharma Private Limited

Data last updated:

Cambiar Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 January 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC113978. Its GSTIN is 36AAGCC8012R1Z8 (Telangana).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Kothawar Sunil Kumar and Boora Sunil Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 05 1st Floor Mehtab Arcade Tarnaka Cross Roads Opp: Ganesh Temple, Secunderabad, Telangana, India – 500017.

As per the financials filed for FY 2023, the company reported a revenue of ₹9.2 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹7,270 (net margin -0.8%) and EBITDA of -₹4,095 (EBITDA margin -0.4%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 3% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Cambiar Pharma Private Limited
CIN U24304TG2017PTC113978
Registration Number 113978
Incorporation Date 10 January 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    05 1st Floor Mehtab Arcade Tarnaka Cross Roads Opp: Ganesh Temple, Secunderabad, Telangana, India – 500017
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Cambiar Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Cambiar Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Cambiar Pharma Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Cambiar Pharma Private Limited

The main business activity of Cambiar Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Cambiar Pharma Private Limited FY 2025 filings available

Cambiar Pharma Private Limited reported revenue of ₹9.2 Lakh (up 20% YoY) for FY 2023.

Revenue · FY 2023
₹9.2 Lakh ▲ 20%
Net loss · FY 2023
₹7,270 margin -0.8%
EBITDA · FY 2023
-₹4,095 margin -0.4%

Compounded Annual Growth Rate (CAGR) of Cambiar Pharma Private Limited

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▼ 13%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 112%
3 years · compounded
▲ 77%
5 years · compounded
▼ 16%

Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Cambiar Pharma Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹9.2 Lakh••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹4,095••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹7,270••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Cambiar Pharma Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-0.4%••••••••••••••••
Net Profit Margin-0.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cambiar Pharma are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Cambiar Pharma Private Limited

Cambiar Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kothawar Sunil KumarDirector23 Jan 20179 Years 8 MonthsCurrent
Boora Sunil KumarDirector10 Jan 20179 Years 9 MonthsCurrent

Peer Comparison of Cambiar Pharma Private Limited

Cambiar Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kalki Pharmaceuticals Private Limited₹9.31 Lakh (FY 2023)••••••••••••Raipur, Chhattisgarh, India
Adsorbtek Solutions Private Limited₹9.26 Lakh (FY 2025)••••••••-88.0%••••Vadodara, Gujarat, India
Ambrans Pharma Private Limited₹9.26 Lakh (FY 2019)••••••••••••Kolkata, West Bengal, India
Bioreo Chemicals & Pharmaceuticals (OPC) Private Limited₹9.25 Lakh (FY 2025)••••••••••••Bangalore, Karnataka, India
Biogen Laboratories (India) Private Limited₹9.2 Lakh (FY 2025)••••••••-63.0%••••Mumbai, Maharashtra, India
Cambiar Pharma Private Limited this company₹9.2 Lakh (FY 2023)••••••••20.0%••••Secunderabad, Telangana, India
SMD Manufacturing Private Limited₹9.17 Lakh (FY 2025)••••••••-21.0%••••Mumbai, Maharashtra, India
Krishniya Private Limited₹9.15 Lakh (FY 2024)••••••••-84.0%••••Mumbai, Maharashtra, India
Instrument Logics & Controls India Private Limited₹9.08 Lakh (FY 2019)••••••••-9.0%••••Coimbatore, Tamil Nadu, India
M.P. Dailyneed Multitrade Private Limited₹9.08 Lakh (FY 2023)••••••••-36.0%••••Karad, Maharashtra, India
RPS Remedies Private Limited₹9.06 Lakh (FY 2021)••••••••135.0%••••New Delhi, Delhi, India

Peers are the five companies nearest above and the five nearest below Cambiar Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Cambiar Pharma Private Limited

Cambiar Pharma Private Limited is audited by PRODDUTURVIJAYABHASKER for the financial year 2023.

NameStatusAppointment DateCessation Date
PRODDUTURVIJAYABHASKERLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Cambiar Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Cambiar Pharma Private Limited

Cambiar Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Cambiar Pharma Private Limited

Employment history and EPFO contributions of people linked to Cambiar Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Cambiar Pharma Private Limited

Cambiar Pharma Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Kothawar Sunil Kumar ceased to be Additional Director on 29 Sep 2017.

AGM
Cambiar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cambiar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Kothawar Sunil Kumar ceased to be Additional Director.
Ceased
Dhage Madhusudan ceased to be Additional Director.
Ceased
Muvva Srikanth ceased to be Director.
Appointed
Kothawar Sunil Kumar was appointed as Director.
Appointed
Boora Sunil Kumar was appointed as Director.
Incorporation
10 Jan 2017
Cambiar Pharma Private Limited was registered on 10 Jan 2017 with Roc Hyderabad & aged 9 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Cambiar Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Cambiar Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Cambiar Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Cambiar Pharma Private Limited

Cambiar Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAGCC8012R1Z8TelanganaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Cambiar Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cambiar Pharma Private Limited

Cambiar Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 January 2017 (9+ years old) and is registered under CIN U24304TG2017PTC113978.

Cambiar Pharma reported revenue of ₹9.2 Lakh for FY 2023 (up 20% YoY).

Cambiar Pharma has 2 current directors:

Cambiar Pharma reported a net loss of ₹7,270 (net margin -0.8%) and EBITDA of -₹4,095 (EBITDA margin -0.4%) for FY 2023, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Cambiar Pharma is -13% over three years and -3% over five years. In the latest year (FY 2023) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Cambiar Pharma is 36AAGCC8012R1Z8, registered in Telangana.

The CIN (Corporate Identification Number) of Cambiar Pharma is U24304TG2017PTC113978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cambiar Pharma was incorporated on 10 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Cambiar Pharma by revenue are Kalki Pharmaceuticals Private Limited, Adsorbtek Solutions Private Limited, Ambrans Pharma Private Limited, Bioreo Chemicals & Pharmaceuticals (OPC) Private Limited, Biogen Laboratories (India) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Kothawar Sunil Kumar ceased to be Additional Director on 29 Sep 2017. Dhage Madhusudan ceased to be Additional Director on 27 Jun 2017. Muvva Srikanth ceased to be Director on 27 Jun 2017. Cambiar Pharma has 5 board changes on record in total.

The registered office of Cambiar Pharma is at 05 1st Floor Mehtab Arcade Tarnaka Cross Roads Opp: Ganesh Temple, Secunderabad, Telangana, India – 500017.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available